News | Intravascular Imaging | February 25, 2022

Dyad Medical Secures FDA Clearance For Cardiac Image Analysis Platform

Libby IAAA’s groundbreaking AI and cloud-based technology aids Intravascular Optical Coherence Tomography image analysis

Intravascular Optical Coherence Tomography (IVOCT)

Intravascular Optical Coherence Tomography (IVOCT)


February 25, 2022Dyad Medical, Inc., the developer of the cloud-based AI technology for cardiac image analysis called Libby, announced that the U.S. Food and Drug Administration (FDA) has cleared Libby IAAA through the 510(k) pathway. Libby IAAA offers image analysis used for viewing and quantifying Intravascular Optical Coherence Tomography (IVOCT) images. The clearance provides healthcare professionals another important tool to automate intravascular investigation, or the ability to see the inside of blood vessels.

“Dyad Medical is proud to offer hospital systems, imaging centers, and researchers a tool to conduct cardiac image analysis in a fraction of the time,” said Dr. Ronny Shalev, CEO and Co-Founder of Dyad Medical. “This new milestone indicates the FDA’s trust in Dyad Medical’s work and enables broader adoption of imaging AI as an integral part of value-based care.”

Coronary artery disease, the most common type of heart disease, is the leading cause of death, disability, and escalating healthcare costs worldwide. It is frequently treated by inserting metal stents in the hearts’ arteries. The stents help hold open the artery, resolving obstructions and blockages that impede coronary blood flow. While drug-eluting stents hinder restenosis, or future blockages, there is room to improve existing treatment options. To optimize stent design, sensitive in vivo, or within the heart, assessments are needed for preclinical and clinical evaluations. IVOCT is the only imaging method with the resolution and contrast able to accomplish this.

Until now, IVOCT imaging has not been widely adopted. It requires operators to manually interpret and analyze cardiac images, taking in a large amount of data in real-time during percutaneous coronary intervention, a minimally invasive procedure used to open clogged coronary arteries. Libby IAAA provides an automated solution in cardiac image analysis and interpretation.

“Stent failure has been linked to inadequate stent expansion, incomplete stent coverage of diseased segments, and untreated dissections at the stent edges,” said Dr. Shalev. “By combining AI and technology innovations, Libby IAAA is able to facilitate thorough stent analysis that will help physicians and researchers make accurate observations and conclusions about overall patient health.”

A leading research hospital has already signed on to use Libby IAAA. Dyad Medical is a member of QualComm’s XR Enterprise Program, the NVIDIA Inception Program and the MassChallenge Boston Accelerator Program.

To learn more about Dyad Medical’s automated medical image analysis products, visit www.dyadmed.com.


Related Content

News | Intravascular Imaging

June 2, 2022 — With over 30 years' experience in vascular assessment, Huntleigh, a member of the Arjo family, has ...

Home June 02, 2022
Home
News | Intravascular Imaging

December 15, 2021 — Conavi Medical Inc. has entered into agreements for over $20 million in funding to support ...

Home December 15, 2021
Home
News | Intravascular Imaging

October 18, 2020 – New data from the PROSPECT II study shows that near-infrared spectroscopy (NIRS) intravascular ...

Home October 18, 2020
Home
Technology | Intravascular Imaging

May 20, 2019 — Philips announced the launch of the new IntraSight interventional applications platform. The secure ...

Home May 20, 2019
Home
Videos | Intravascular Imaging

Ron Waksman, M.D., associate director of the division of cardiology and director of cardiovascular research and advanced ...

Home September 26, 2018
Home
News | Intravascular Imaging

September 25, 2018 – New data demonstrate the correlation between the presence of non-flow-limiting, non-intervened-upon ...

Home September 25, 2018
Home
News | Intravascular Imaging

August 10, 2018 — Infraredx Inc. announced the Makoto Intravascular Imaging System, and accompanying Dualpro ...

Home August 10, 2018
Home
Technology | Intravascular Imaging

May 2, 2018 — Conavi Medical Inc. has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its ...

Home May 02, 2018
Home
Videos | Intravascular Imaging

A discussion with Ron Waksman, M.D., associate director of the division of cardiology and director of cardiovascular ...

Home March 27, 2018
Home
Technology | Intravascular Imaging

January 11, 2017 — Avinger Inc. recently announced the U.S. launch of an enhanced version of the company’s Lightbox ...

Home January 11, 2017
Home
Subscribe Now